Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices

You can add yet another Big Pharma to the list of companies swearing off US price hikes.

Roche tells me this morning that they told HHS on July 11 — the day after Pfizer CEO Ian Read agreed to roll back a price hike in a call with the president — that “we will not be taking any price increases for the remainder of the year.”